Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical trial protocol
GLP-1受体激动剂索玛鲁肽在门诊阿片类药物使用障碍患者中戒断非法和非处方阿片类药物的疗效:一项随机、双盲、安慰剂对照临床试验方案
期刊:Addiction Science & Clinical Practice
影响因子:3.2
doi:10.1186/s13722-025-00618-2
Freet, Christopher S; Shuler, Kirsten; Kawasaki, Sarah; Weintraub, Eric; Greenblatt, Aaron; Kladney, Mat; Nunes, Edward; Foster, Katrina L; Kong, Lan; Raja-Khan, Nazia; Cleveland, H Harrington; Grigson, Patricia S; Bunce, Scott C; Brick, Timothy R; Nyland, Jennifer E